Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 4 5Phase 2 4Phase EARLY_PHASE1 3Phase 3 3Phase 2/3 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Arthralgia 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Fish Oils × Clear all
NCT06123286 2026-05-05

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Breast

Breast Neoplasms, Arthralgia

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

University of Colorado, Denver

Phase EARLY_PHASE1 Completed
42 enrolled
Breast

Breast Neoplasms

NCT02538484 2023-07-17

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
24 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡